©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Dosage and utilization of dexamethasone in the management of COVID-19: A critical review
Imran Sethi, Asim Shaikh, Musa Sethi, Hira Khalid Chohan, Sheraz Younus, Syed A Khan, Salim Surani
Imran Sethi, Department of Critical Care Medicine, Marion General Hospital, Marion, IN 46952, United States
Asim Shaikh, Department of Medicine, Aga Khan University, Karachi 74200, Sindh, Pakistan
Musa Sethi, Department of Medicine, Eman School, Fishers, IN 46038, United States
Hira Khalid Chohan, Department of Internal Medicine, Dow University of Health Science, Karachi 74200, Sindh, Pakistan
Sheraz Younus, Department of Hospital Medicine, Franciscan Health, Indianapolis, IN 46237, United States
Syed A Khan, Department of Critical Care Medicine, Mayo Clinic Health System, Mankato, MN 56001, United States
Salim Surani, Department of Medicine and Pharmacology, Texas A and M University, College Station, TX 77843, United States
Author contributions: Sethi I provided the conceptualization; Sethi I, Shaikh A, Sethi M, Chohan HK, and Younus S provided the literature review, drafting, and reviewing; Sethi I, Shaikh A, Sethi M agreed to the final accuracy of the work; Khan SA and Surani S provided supervision, idea generation, and critical final review of the manuscript.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
PRISMA 2009 Checklist statement: The authors have read the PRISMA 2009 Checklist, and the manuscript was prepared and revised according to the PRISMA 2009 Checklist.
Corresponding author: Salim Surani, FACP, FCCP, MD, MHSc, Adjunct Professor, Depart
ment of Medicine and Pharmacology, Texas A and M University, 40 Bizzell Street, College Station, TX 77843, United States.
srsurani@hotmail.com
Received: April 16, 2024
Revised: May 27, 2024
Accepted: June 19, 2024
Published online: September 25, 2024
Processing time: 134 Days and 19 Hours
